跳至主要内容
临床试验/CTRI/2020/02/023446
CTRI/2020/02/023446尚未招募未知

Comparative efficacy, tolerability and treatment adherence of oral and long acting injectable antipsychotic in first episode schizophrenia.

Government Medical College and Hospital Chandigarh Sector0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients diagnosed with schizophrenia as per DSM-5
  • 2)Total duration of illness shall be less than one year.
  • 3)Age of the patients shall be between 18-45 years.
  • 4)Drug naïve or not on any psycho tropics for 2 weeks.
  • 5)Patients willing to participate and give consent or in case the patient lacks mental capacity, his/her nominated representative gives consent to participate.

排除标准

  • 1)Patients who are not willing to give consent.
  • 2)Pregnant and breast feeding patients.
  • 3)Patients with co-morbid psychiatric illness and substance dependence.
  • 4)Patients with severe medical and surgical illness.
  • 5)Patients with high suicidal risk( Beckâ??s scale for suicidal ideation score >29)
  • 6)Patients with history of sensitivity to haloperidol in the past.
  • 7)Patients with history of depot antipsychotic administration in the past.
  • 8)Patients with no response to haloperidol in the past or those reporting non-tolerability to the drug in the past.
  • 9)Patients who had received ECT in the past.

研究者

发起方
Government Medical College and Hospital Chandigarh Sector

相似试验